BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 17478338)

  • 1. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
    Richer S; Devenport J; Lang JC
    Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration.
    Weigert G; Kaya S; Pemp B; Sacu S; Lasta M; Werkmeister RM; Dragostinoff N; Simader C; Garhöfer G; Schmidt-Erfurth U; Schmetterer L
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8174-8. PubMed ID: 21873668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation.
    Wenzel AJ; Sheehan JP; Gerweck C; Stringham JM; Fuld K; Curran-Celentano J
    Ophthalmic Physiol Opt; 2007 Jul; 27(4):329-35. PubMed ID: 17584283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term plant stanol and sterol ester-enriched functional food consumption, serum lutein/zeaxanthin concentration and macular pigment optical density.
    Berendschot TT; Plat J; de Jong A; Mensink RP
    Br J Nutr; 2009 Jun; 101(11):1607-10. PubMed ID: 18986598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).
    Richer S; Stiles W; Statkute L; Pulido J; Frankowski J; Rudy D; Pei K; Tsipursky M; Nyland J
    Optometry; 2004 Apr; 75(4):216-30. PubMed ID: 15117055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial.
    Bartlett HE; Eperjesi F
    Eur J Clin Nutr; 2007 Sep; 61(9):1121-7. PubMed ID: 17268417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
    Ma L; Dou HL; Huang YM; Lu XR; Xu XR; Qian F; Zou ZY; Pang HL; Dong PC; Xiao X; Wang X; Sun TT; Lin XM
    Am J Ophthalmol; 2012 Oct; 154(4):625-634.e1. PubMed ID: 22835510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular pigment and lutein supplementation in choroideremia.
    Duncan JL; Aleman TS; Gardner LM; De Castro E; Marks DA; Emmons JM; Bieber ML; Steinberg JD; Bennett J; Stone EM; MacDonald IM; Cideciyan AV; Maguire MG; Jacobson SG
    Exp Eye Res; 2002 Mar; 74(3):371-81. PubMed ID: 12014918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.
    Rodriguez-Carmona M; Kvansakul J; Harlow JA; Köpcke W; Schalch W; Barbur JL
    Ophthalmic Physiol Opt; 2006 Mar; 26(2):137-47. PubMed ID: 16460314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
    Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
    J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of macular pigment augmentation on visual performance using different carotenoid formulations.
    Loughman J; Nolan JM; Howard AN; Connolly E; Meagher K; Beatty S
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7871-80. PubMed ID: 23132800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.
    Schalch W; Cohn W; Barker FM; Köpcke W; Mellerio J; Bird AC; Robson AG; Fitzke FF; van Kuijk FJ
    Arch Biochem Biophys; 2007 Feb; 458(2):128-35. PubMed ID: 17084803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macular pigment and age-related macular degeneration. Clinical implications].
    Haddad WM; Souied E; Coscas G; Soubrane G
    Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular pigment and healthy vision.
    Optometry; 2009 Oct; 80(10):592-8. PubMed ID: 20576249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy.
    Sawa M; Gomi F; Hara C; Nishida K
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5238-44. PubMed ID: 25074771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance.
    Kvansakul J; Rodriguez-Carmona M; Edgar DF; Barker FM; Köpcke W; Schalch W; Barbur JL
    Ophthalmic Physiol Opt; 2006 Jul; 26(4):362-71. PubMed ID: 16792735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration.
    Stringham JM; Hammond BR; Nolan JM; Wooten BR; Mammen A; Smollon W; Snodderly DM
    Exp Eye Res; 2008 Nov; 87(5):445-53. PubMed ID: 18778703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.